| Liu |
NCT06755151: Fenofibrate in Primary Biliary Cholangitis: a Real World Study |
|
|
| Recruiting | 3 | 300 | RoW | Fenofibrate | Xijing Hospital of Digestive Diseases | Primary Biliary Cholangitis (PBC) | 12/35 | 12/35 | | |
NCT06755541: Fenofibrate in Combination With Ursodeoxycholic Acid in Primary Biliary Cholangitis: a Real World Study |
|
|
| Recruiting | 3 | 150 | RoW | Fenofibrate in Combination With Ursodeoxycholic Acid | Xijing Hospital of Digestive Diseases | Primary Biliary Cholangitis (PBC) | 12/35 | 12/35 | | |
NCT05668988: A Study of DZD9008 Versus Platinum-Based Doublet Chemotherapy in Local Advanced or Metastatic Non-small Cell Lung Cancer (WU-KONG28) |
|
|
| Recruiting | 3 | 320 | Europe, Canada, US, RoW | DZD9008, Pemetrexed+carboplatin | Dizal Pharmaceuticals | Non-small Cell Lung Cancer | 02/26 | 10/27 | | |
| Active, not recruiting | 3 | 9541 | Europe, Canada, Japan, US, RoW | Obicetrapib, Placebo | NewAmsterdam Pharma, Monash University | Atherosclerotic Cardiovascular Disease | 11/26 | 11/26 | | |
JACKPOT8, NCT04105010: Assessing An Oral Janus Kinase Inhibitor, AZD4205 as Monotherapy in Patients Who Have PTCL |
|
|
| Completed | 2 | 171 | US, RoW | AZD4205 | Dizal Pharmaceuticals | Relapsed or Refractory Peripheral T Cell Lymphoma | 10/23 | 02/24 | | |
NCT06175351: Study to Evaluate the Pharmacokinetic Characteristics, Safety, Tolerability, and Preliminary Efficacy of 9MW1911 in Patients With Chronic Obstructive Pulmonary Disease (COPD). |
|
|
| Recruiting | 1/2 | 80 | RoW | 9MW1911, Placebo | Mabwell (Shanghai) Bioscience Co., Ltd. | Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) | 09/25 | 09/25 | | |
| Recruiting | 1 | 230 | US, RoW | DZD8586 | Dizal Pharmaceuticals | Lymphoma, Non-Hodgkin | 04/27 | 10/27 | | |
| Li, Xiaorong |
NCT05520177: A Phase III Study for 601 Versus Ranibizumab in Patients With Vision Loss |
|
|
| Recruiting | 3 | 350 | RoW | 601 1.25mg, 601, ranibizumab 0.5mg, Lucentis | Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. | Branch Retinal Vein Occlusion | 12/25 | 12/25 | | |
NCT04667910: 601 Versus Ranibizumab in Patients With Central Retinal Vein Occlusion (CRVO) |
|
|
| Not yet recruiting | 2 | 60 | RoW | 601 1.25mg, Drug 601, Ranibizuman 0.5 mg, Lucentis | Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. | Central Retinal Vein Occlusion | 07/22 | 01/23 | | |
NCT04048421: Feasibility and Safety of Hybrid Transvaginal Natural Orifice Transluminal Endoscopic Surgery for Colon Cancer |
|
|
| Recruiting | 2 | 55 | RoW | hvNOTES radical colectomy | Renmin Hospital of Wuhan University | Colon Cancer, Natural Orifice Transluminal Endoscopic Surgery | 11/24 | 11/25 | | |
| Recruiting | 1/2 | 78 | RoW | FT-003 | Frontera Therapeutics, Tianjin Medical University Eye Hospital, The First Affiliated Hospital of Soochow University, Peking Union Medical College Hospital, Beijing Hospital | Neovascular Age-related Macular Degeneration | 10/24 | 10/28 | | |
| Recruiting | 1/2 | 78 | RoW | FT-003 | Frontera Therapeutics | Diabetic Macular Edema | 11/24 | 11/28 | | |
NCT05832684: Safety and Efficacy of ZVS101e in Patients With Bietti 's Crystalline Dystrophy |
|
|
| Active, not recruiting | 1/2 | 24 | RoW | ZVS101e, rAAV2/8-hCYP4V2, rAAV8-hCYP4V2, AAV8-hCYP4V2 | Chigenovo Co., Ltd | Bietti's Crystalline Dystrophy | 12/24 | 12/28 | | |
NCT05639530: A Dose Escalation Study of IBI333 in Subjects With Neovascular Age-related Macular Degeneration |
|
|
| Completed | 1 | 17 | RoW | IBI333 | Innovent Biologics (Suzhou) Co. Ltd. | Neovascular Age-related Macular Degeneration | 12/23 | 04/24 | | |
NCT06412224: The Preliminary Safety and Efficacy of RRG001 After Vitrectomy in Subjects With Proliferative Diabetic Retinopathy (PDR) |
|
|
| Recruiting | 1 | 6 | RoW | RRG001 | Li Xiaorong, Shanghai Refreshgene Technology Co., Ltd. | PDR - Proliferative Diabetic Retinopathy | 12/24 | 12/28 | | |
| Not yet recruiting | 1 | 18 | NA | FT-003 | Frontera Therapeutics, The First Affiliated Hospital of Soochow University, Tianjin Medical University Eye Hospital, Peking Union Medical College Hospital, The First Affiliated Hospital of Zhengzhou University | Neovascular Age-related Macular Degeneration | 11/24 | 12/27 | | |
NCT06031727: CRISPR/cas13-medIated RNA TarGeting THerapy for the Treatment of Neovascular Age-related Macular Degeneration Investigator-initiated Trial (SIGHT-I) |
|
|
| Recruiting | 1 | 12 | RoW | HG202 | HuidaGene Therapeutics Co., Ltd., Tianjin Medical University Eye Hospital, Eye & ENT Hospital of Fudan University | Neovascular Age-related Macular Degeneration(nAMD) | 12/24 | 06/25 | | |
| Recruiting | 1 | 18 | RoW | FT-003 | Frontera Therapeutics, Tianjin Medical University Eye Hospital, Peking Union Medical College Hospital, The First Affiliated Hospital of Zhengzhou University | Diabetic Macular Edema | 05/25 | 05/28 | | |
NCT03525028: A Clinical Trial of Metformin to Decrease Glucocorticoids Side Effects in Patients With Autoimmune Uveitis |
|
|
| Recruiting | N/A | 138 | RoW | Metformin, Placebo | Tianjin Medical University, Peking Union Medical College Hospital, Peking University First Hospital, Zhongshan Ophthalmic Center, Sun Yat-sen University | Uveitis, Metformin, Glucocorticoid | 01/23 | 01/23 | | |
NACSOC, NCT02972541: Neoadjuvant Chemotherapy Verse Surgery Alone After Stent Placement for Obstructive Colonic Cancer |
|
|
| Recruiting | N/A | 248 | RoW | Stenting with neoadjuvant chemotherapy, Stenting with immediate Surgery | Beijing Chao Yang Hospital | Colorectal Cancer, Neoadjuvant Chemotherapy, Stent, Obstruction | 12/23 | 12/23 | | |
| Recruiting | N/A | 18000 | RoW | | Li Xiaorong, Tianjin Medical University Eye Hospital | Diabetic Retinopathy | 03/25 | 03/25 | | |
NCT05852132: Clinical Study on Prognosis of Patients With Severe NPDR Undergoing Vitrectomy |
|
|
| Not yet recruiting | N/A | 249 | RoW | pars plana vitrectomy(PPV), Pars plana vitrectomy(PPV) +Panretinal photocoagulation(PRP), Panretinal photocoagulation(PRP) | Fei Gao | Non Proliferative Diabetic Retinopathy(NPDR) | 03/26 | 10/26 | | |
| Zhang, Xiao |
NCT05438875: The Combination of ATRA and Eltrombopag as the Treatment of Steroid-resistant/Relapse ITP Based on MSC-C5b-9 |
|
|
| Recruiting | 3 | 96 | RoW | all-trans retinoic acid, retinoic acid, Eltrombopag, TPO-RA | Peking University People's Hospital, Beijing Friendship Hospital, Beijing Tongren Hospital, Beijing Hospital, Navy General Hospital, Beijing | Purpura, Thrombocytopenic, Idiopathic | 12/24 | 03/25 | | |
| Completed | 2 | 20 | RoW | Zanubrutinib | Peking University People's Hospital | Immune Thrombocytopenia, Bruton Tyrosine Kinase | 10/22 | 10/22 | | |
NCT05302024: Efficacy and Safety of Iguratimod in the Treatment of Steroid-resistant/Relapse Immune Thrombocytopenia |
|
|
| Not yet recruiting | 2 | 100 | RoW | Iguratimod | Peking University People's Hospital | Immune Thrombocytopenia | 12/23 | 12/23 | | |
NCT05852847: Low-dose Baricitinib Plus Danazol for Steroid-resistant/Relapse Immune Thrombocytopenia |
|
|
| Recruiting | 2 | 216 | RoW | Baricitinib 2 MG [Olumiant], Olumiant, Danazol | Peking University People's Hospital, Beijing Luhe Hospital, Chinese PLA General Hospital, Navy General Hospital, Beijing, Beijing Hospital, Beijing Friendship Hospital, Peking University First Hospital, Peking University Third Hospital, China-Japan Friendship Hospital, Beijing Tsinghua Changgeng Hospital | Immune Thrombocytopenia | 11/24 | 05/25 | | |
| Completed | 2 | 456 | Europe, Japan, US, RoW | Enpatoran low dose, M5049, Enpatoran medium dose, Enpatoran high dose, Placebo | EMD Serono Research & Development Institute, Inc., Merck KGaA, Darmstadt, Germany | Systemic Lupus Erythematosus | 11/24 | 11/24 | | |
|
|
AF BP, NCT06433336: Effect of Blood Pressure on Cardiovascular Outcomes and Recurrence After Catheter Ablation in Patients With Atrial Fibrillation |
|
|
| Completed | N/A | 800 | RoW | | The Second Hospital of Lanzhou University | Atrial Fibrillation, Persistent, Blood Pressure | 05/24 | 05/24 | | |
NCT04029324: Clinical Outcomes of Immediate Implant Placement and Early Implant Placement |
|
|
| Recruiting | N/A | 100 | RoW | tooth extraction, Implant placement, Bone augmentation, Coronally repositioned flap | Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University | Tooth Fractures, Tooth Diseases | 12/21 | 10/22 | | |
NCT04214951: A Study of Eltrombopag and Recombinant Human Thrombopoietin In Primary Immune Thrombocytopenia |
|
|
| Active, not recruiting | N/A | 100 | RoW | Eltrombopag, Recombinant human thrombopoietin (rh-TPO) | Peking University People's Hospital | Corticosteroid-resistant or Relapsed ITP | 08/22 | 12/22 | | |
GIANT, NCT04765592: Guo's Aortic Arch Reconstruction :The Prospective ,Multiple Center Study About the Safety and Efficacy of WeFlow-Arch Modeler Embedded Branch Stent Graft System ( Study) |
|
|
| Active, not recruiting | N/A | 88 | RoW | WeFlow-Arch Modeler Embedded Branch Stent Graft System | Hangzhou Endonom Medtech Co., Ltd. | Aortic Arch Aneurysm | 02/25 | 02/29 | | |
NCT05278507: Comparing Arrow PICC Catheters w/ Arrowga+rd Blue Advanced Protection Performance and Safety to Unprotected PICC's |
|
|
| Recruiting | N/A | 444 | RoW | Arrowga+rd Blue Advance Protection PICC Placement, Sham Comparator PICC placement | Teleflex | Peripherally Inserted Central Catheter | 06/23 | 06/23 | | |
NCT06331923: Assessing the Effectiveness of Continuous Glucose Monitoring in Enhancing Surgical Outcomes for Patients with Diabetes |
|
|
| Recruiting | N/A | 10168 | RoW | Continuous glucose monitoring (CGM) device | Beijing Tsinghua Chang Gung Hospital, Peking University International Hospital, Wang Jing Hospital, ZhuHai Hospital, Beijing Hospital, Siyang County Hospital of Traditional Chinese Medicine, Second Hospital of Shanxi Medical University, Henan Provincial Chest Hospital, Fuzhou First Hospital, Pinggu Hospital of Beijing Traditional Chinese Medicine Hospital, The First Affiliated Hospital of Anhui University of Chinese Medicine, The First Affiliated Hospital of Zhengzhou University, Mindong Hospital of Ningde, The Fifth Hospital of Xiamen, People's Hospital of Ningxia Hui Autonomous Region, The First People's Hospital of Changzhou, The Fifth hospital of Deyang, Suzhou Municipal Hospital, Tang-Du Hospital, Yiyang Central Hospital, First Affiliated Hospital of Xinjiang Medical University, Peng Ding Shan Shi Zhong Yi Yi Yuan, Yueyang Central Hospital, The First People's Hospital of Lianyungang, Haimen District Traditional Chinese Medicine Hospital, The 910th Hospital, The Second Affiliated Hospital of Zhejiang Chinese Medical University, Beijing Tiantan Hospital, Affiliated Hospital of Jiangsu University, Liaocheng People's Hospital, Beijing Chao Yang Hospital, Jilin City Hospital of Chemical Industry, Creen Hospital-465, Wuhan Central Hospital, Air Force Military Medical University, China, Shanghai Tong Ren Hospital, Beijing Anzhen Hospital, Emergency General Hospital, Beijing Tongren Hospital, Civil Aviation General Hospital, Peking University Shougang Hospital, The First Affiliated Hospital of Anhui Medical University, Chinese PLA Central Hospital | Comprehensive Complication Index | 10/25 | 12/25 | | |
NCT06491979: Vitamin and Unsaturated Fatty Acid Supplements in Healthy and Uveitis Human Subjects |
|
|
| Completed | N/A | 7 | RoW | Vitamin A treatment, Monounsaturated fatty acid mixture, Polyunsaturated fatty acid mixture, Fatty acid mixture | Tianjin Medical University | Healthy, Uveitis, Autoimmune Diseases | 08/24 | 10/24 | | |
NCT06727669: Longitudinal Cohort of Thrombosis and Hemostasis Diseases |
|
|
| Recruiting | N/A | 3000 | RoW | | Peking University People's Hospital | Immune Thrombocytopenia, Thrombotic Thrombocytopenic Purpura, Hemophilia A, Acquired, Disseminated Intravascular Coagulation, Thrombophilia, Deep Vein Thrombosis, Pulmonary Embolism, Thrombotic Microangiopathies, Coagulation Factor Deficiency, Hemophilia A, Hemophilia B, Hemophilia B, Acquired, Platelet Dysfunction, Arterial Thromboembolism, Bleeding Disorder, Thrombosis | 12/29 | 12/30 | | |
NCT05409482: A Real-world Study of Camrelizumab Combined With Apatinib Mesylate in Unresectable Hepatocellular Carcinoma |
|
|
| Recruiting | N/A | 300 | RoW | | Meng Chao Hepatobiliary Hospital of Fujian Medical University, Suzhou Suncadia Biopharmaceuticals Co., Ltd. | Hepatocellular Carcinoma | 03/26 | 03/26 | | |
| Recruiting | N/A | 75 | RoW | Carotid endarterectomy (CEA), Carotid artery stenting (CAS) | Xuanwu Hospital, Beijing | Radiation-induced Carotid Artery Stenosis | 12/26 | 12/27 | | |
| Li |
| Active, not recruiting | 3 | 41 | Europe, Canada, Japan, US, RoW | Emapalumab, NI-0501, emapalumab-lzsg, ATC code: L04AA39 (WHO) | Swedish Orphan Biovitrum | Macrophage Activation Syndrome, Secondary Hemophagocytic Lymphohistiocytosis, Still Disease, Systemic Lupus Erythematosus, SJIA, AOSD, MAS | 06/24 | 09/25 | | |
NCT06683651: A Study in Chinese Patients With Acquired Blepharoptosis |
|
|
| Recruiting | 3 | 180 | RoW | STN1013800 ophthalmic solution, STN1013800 ophthalmic solution Liquid Base, without STN1013800 | Santen Pharmaceutical Co., Ltd. | Blepharoptosis | 06/26 | 06/26 | | |
NCT05751967: Fenofibrate Combined with Ursodeoxycholic Acid in Subjects with Primary Biliary Cholangitis |
|
|
| Recruiting | 3 | 150 | RoW | Placebo Combined With Ursodeoxycholic Acid, UDCA 13-15mg/kg/d, Fenofibrate Combined With Ursodeoxycholic Acid | Xijing Hospital of Digestive Diseases | Primary Biliary Cholangitis | 12/25 | 12/25 | | |
NCT05668988: A Study of DZD9008 Versus Platinum-Based Doublet Chemotherapy in Local Advanced or Metastatic Non-small Cell Lung Cancer (WU-KONG28) |
|
|
| Recruiting | 3 | 320 | Europe, Canada, US, RoW | DZD9008, Pemetrexed+carboplatin | Dizal Pharmaceuticals | Non-small Cell Lung Cancer | 02/26 | 10/27 | | |
NCT06174402: Fenofibrate in Combination with Ursodeoxycholic Acid in Primary Biliary Cholangitis |
|
|
| Recruiting | 2/3 | 184 | RoW | Fenofibrate, Placebo, UDCA | Han Ying | Primary Biliary Cholangitis | 12/25 | 12/25 | | |
NCT05749822: Fenofibrate for Compensated Cirrhosis Patients with Primary Biliary Cholangitis |
|
|
| Recruiting | 2/3 | 104 | RoW | Fenofibrate 200mg, Placebo, UDCA | Xijing Hospital of Digestive Diseases | Primary Biliary Cholangitis | 12/25 | 12/25 | | |
JACKPOT8, NCT04105010: Assessing An Oral Janus Kinase Inhibitor, AZD4205 as Monotherapy in Patients Who Have PTCL |
|
|
| Completed | 2 | 171 | US, RoW | AZD4205 | Dizal Pharmaceuticals | Relapsed or Refractory Peripheral T Cell Lymphoma | 10/23 | 02/24 | | |
NCT04614740: The Phase I/Phase II Clinical Study of VC004 in Patients With Localized Advanced/Metastatic Solid Tumors |
|
|
| Recruiting | 2 | 115 | RoW | VC004 | Jiangsu vcare pharmaceutical technology co., LTD | Locally Advanced Solid Tumor, Metastatic Solid Tumor | 01/24 | 06/24 | | |
NCT05527912: A Phase II Study of Rituximab, Chidamide, Zanubrutinib-induced and CHOP Therapy |
|
|
| Recruiting | 2 | 45 | RoW | Rituximab, Chidamide, Zanubrutinib-induced and CHOP Therapy, RCZ WITH CHOP | Sun Yat-sen University | Double Express Diffuse Large B-cell Lymphoma | 09/24 | 12/24 | | |
NCT06175351: Study to Evaluate the Pharmacokinetic Characteristics, Safety, Tolerability, and Preliminary Efficacy of 9MW1911 in Patients With Chronic Obstructive Pulmonary Disease (COPD). |
|
|
| Recruiting | 1/2 | 80 | RoW | 9MW1911, Placebo | Mabwell (Shanghai) Bioscience Co., Ltd. | Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) | 09/25 | 09/25 | | |
NCT06302608: Safety and Efficacy Study of NGGT001 in Bietti Crystalline Corneoretinal Dystrophy |
|
|
| Active, not recruiting | 1 | 6 | RoW | NGGT001 | Xiamen Ophthalmology Center Affiliated to Xiamen University | Bietti's Crystalline Dystrophy | 05/24 | 05/28 | | |
| Recruiting | 1 | 60 | RoW | BT02 monoclonal antibody injection | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Advanced Solid Tumor | 12/24 | 12/24 | | |
NCT05508100: Dose Confirmation and Dose Expansion Phase 1 Study of IO-108 and IO-108 + Anti-PD-1 in Solid Tumors |
|
|
| Completed | 1 | 38 | RoW | IO-108, IO-108 + pembrolizumab, IO-108 + Keytruda®, IO-108 + tislelizumab | Immune-Onc Therapeutics | Advanced Solid Tumor | 04/24 | 04/24 | | |
NCT06169449: Weight Management in Overweight Endometrial Cancer Patients Undergoing Fertility-sparing Treatment |
|
|
| Recruiting | N/A | 240 | RoW | Weight management--diet, Weight management--exercise, Weight management--accompany, Weight management--refresh, Control group | Peking University People's Hospital | Endometrium Cancer | 12/24 | 12/24 | | |
CONCORDE, NCT06127420: Comprehensive Assessment on Diagnostic and Prognostic Performance of Coronary Physiological Indices |
|
|
| Active, not recruiting | N/A | 3000 | RoW | coronary physiological indices | Shanghai Zhongshan Hospital | Coronary Artery Disease | 05/24 | 11/24 | | |
EXPECT, NCT04375319: OCT Evaluation of Early Vascular Repair in Patients With Non ST Elevation Acute Coronary Syndrome (NSTE-ACS) |
|
|
| Recruiting | N/A | 60 | RoW | OCT, optical coherence tomography | Xuzhou Third People's Hospital, Shandong Jiwei Medical Products Co., Ltd | Unstable Anginas, Non ST Segment Elevation Myocardial Infarction | 12/23 | 12/23 | | |
NCT06202807: Effect of Intermittent Oro-esophageal Tube vs. Nasogastric Tube on Feeding Amount in Stroke Patients |
|
|
| Withdrawn | N/A | 80 | RoW | Intermittent Oro-esophageal Tube Feeding, Nasogastric Tube Feeding, comprehensive rehabilitation therapy | Zeng Changhao, The First Affiliated Hospital of Zhengzhou University | Ischemic Stroke | 04/24 | 04/24 | | |
| Withdrawn | N/A | 80 | RoW | Rehabilitation therapy, Stellate ganglion block | Zeng Changhao, The First Affiliated Hospital of Zhengzhou University | Traumatic Brain Injury | 04/24 | 05/24 | | |
| Withdrawn | N/A | 80 | RoW | Routine therapy, Stellate ganglion block | Zeng Changhao, The First Affiliated Hospital of Zhengzhou University | Autistic Disorder | 05/24 | 05/24 | | |
NCT06271395: Ultrasound-guided Botulinum Toxin Injection on Cricopharyngeal Muscle Dysfunction |
|
|
| Recruiting | N/A | 30 | RoW | Injectable Type A Botulinum Toxin, Botulinum Toxin Injection | Zeng Changhao | Cricopharyngeal Achalasia | 10/24 | 10/24 | | |
IOE-Xinli, NCT06265805: Effect of Different Feeding Modes on Psychological Condition and Experience in Stroke Patients |
|
|
| Recruiting | N/A | 80 | RoW | comprehensive rehabilitation therapy, Intermittent Oro-esophageal Tube Feeding, Nasogastric Tube Feeding | Zeng Changhao, The First Affiliated Hospital of Zhengzhou University | Ischemic Stroke | 12/24 | 12/24 | | |
NCT06020690: A Clinical Study to Evaluate the Safety and Effectiveness of Novabel Bioabsorbable Steroid-releasing Stent for the Chronic Sinusitis |
|
|
| Recruiting | N/A | 93 | RoW | bioabsorbable steroid-releasing stent, functional endoscopic sinus surgery | Enlight Medical Technologies (Shanghai) Co., Ltd | Chronic Sinusitis | 09/24 | 09/25 | | |
ALTER-BC-005, NCT06734533: Anlotinib-based Combination Therapy in Patients with Hormone Receptor-positive（HR+） Metastatic Breast Cancer(MBC) . |
|
|
| Recruiting | N/A | 80 | RoW | Anlotinib+eribulin/nab-paclitaxel/etoposide/capecitabine/pembrolizumab/ sintilimab/ fulvestrant, etc | Hunan Cancer Hospital | HR+ Breast Cancer | 12/25 | 12/25 | | |
NCT06761534: Development and Verification of a Screening Tool for Comprehensive Geriatric Assessment of Elderly Tumor Patients |
|
|
| Not yet recruiting | N/A | 678 | RoW | Screening of comprehensive geriatic assessment., the G8 assessment, Comprehensive Geriatric Assessment (CGA) | Sichuan Cancer Hospital and Research Institute | Geriatric Assessment, Geriatric Patients, Patients with Cancer, Assessment Tool | 12/25 | 12/25 | | |
NCT05714566: Research on Gut Microbiome and Metabolomics Alterations in C.Difficile Infected IBD Patients |
|
|
| Recruiting | N/A | 100 | RoW | Clostridioides difficile toxin detection | RenJi Hospital | Inflammatory Bowel Diseases, Clostridium Difficile Infections, Microtia | 06/24 | 12/24 | | |
| Xiaorong, Li |
NCT06141460: Safety and Efficacy of RRG001 Gene Therapy in Subjects With Neovascular Age-related Macular Degeneration (nAMD) |
|
|
| Recruiting | 1/2 | 48 | RoW | RRG001 | Shanghai Refreshgene Technology Co., Ltd. | Neovascular Age-related Macular Degeneration | 04/26 | 12/30 | | |
| Hu, Bojie |
NCT05990829: Compare the Efficacy of VItrectomy Combined With DExamethasone Implant Versus With Aflibercept in DME Patients Diagnosed by Intraoperative OCT (the VIDEO Study): Study Protocol for a Randomized Controlled Trial |
|
|
| Recruiting | 4 | 64 | RoW | Ozurdex, Aflibercept | Tianjin Medical University Eye Hospital, Abbvie Pharmaceutical Trading (Shanghai) Co., Ltd. | Diabetic Macular Edema, Pars Plana Vitrectomy, Dexamethasone Intravitreal Implant, Intraoperative Optical Coherence Tomography | 10/24 | 04/25 | | |
NCT05248334: A Prospective Study of Ranibizumab in the Treatment of Postoperative Recurrent Vitreous Haemorrhage of Diabetic Retinopathy |
|
|
| Recruiting | 1 | 120 | RoW | Ranibizumab Injection, Panretinal photocoagulation, PPV | Tianjin Medical University Eye Hospital, Hebei Provincial Eye Hospital, Cangzhou Eye Hospital | Diabetic Retinopathy, Postoperative Recurrent Vitreous Hemorrhage, Pars Plana Vitrectomy, Ranibizumab | 12/24 | 12/24 | | |
NCT05757349: Analysis of Novel Positioning Sensor-assisted Postoperative Position Correction and Effective Prone Time Recorded in Patients With Different Prone Times After Macular Hole Surgery |
|
|
| Recruiting | N/A | 86 | RoW | Face-down position time 1-day, Face-down position time 3-day | Tianjin Medical University Eye Hospital | Idiopathic Macular Hole, Effective Prone Time | 03/24 | 03/24 | | |
NCT05728476: Microinvasive Pars Plana Vitrectomy Combined ILM Peeling Versus Anti-VEGF Intravitreal Injection for Treatment-naïve Diabetic Macular Edema |
|
|
| Recruiting | N/A | 102 | RoW | Vitrectomy combined with ILM peeling, Conbercept intravitreal injection | Tianjin Medical University Eye Hospital | Diabetic Macular Edema, Pars Plana Vitrectomy, Conbercept | 09/25 | 09/26 | | |
NCT05631054: Establishment and Validation of a Risk Prediction Model for Long-term Low Vision After Vitrectomy in PDR Patients |
|
|
| Recruiting | N/A | 250 | RoW | | Tianjin Medical University Eye Hospital | Proliferative Diabetic Retinopathy, Pars Plana Vitrectomy, Risk Prediction Model | 06/23 | 06/23 | | |
| Zhang, Xiaomin |
NCT04150770: A Clinical Trial of Infliximab for Childhood Uveitis |
|
|
| Active, not recruiting | 4 | 10 | NA | infliximab, Remicade | Xiaomin Zhang | Uveitis, Infliximab | 01/20 | 12/22 | | |
NCT05180526: Assessment of Safety , Clinical Efficacy with QLETLI in Non-infectious Uveitis (UV) |
|
|
| Active, not recruiting | 4 | 60 | RoW | QLETLI | Bio-Thera Solutions | Uveitis | 12/24 | 12/24 | | |
NCT06238336: Clinical Study of CAR-T Technology for the Treatment of Relapsed Refractory Malignant Haematological Tumours |
|
|
| Recruiting | 2/3 | 30 | RoW | CAR-T cell therapy | Shanxi Bethune Hospital | Hematological Malignancy | 11/25 | 12/25 | | |
YXLL-2022-073, NCT06255847: Clinical Study of Reduced-dose Pomalidomide and Cyclophosphamide Combined With Dexamethasone in the Treatment of Patients With Debilitating RRMM |
|
|
| Recruiting | 2 | 43 | RoW | Pomalidomide, cyclophosphamide combined with dexametha | Shanxi Bethune Hospital | Multiple Myeloma in Relapse | 06/25 | 06/25 | | |
NCT05911503: Clinical Study of High Concentration Ganciclovir Eye Drops in the Treatment of Cytomegalovirus Retinitis |
|
|
| Recruiting | 1 | 15 | RoW | 2% Ganciclovir Eye Drops | Tianjin Medical University | Cytomegalovirus Retinitis, Ganciclovir Eye Drops | 06/27 | 06/27 | | |
NCT03389191: A Clinical Trial of Acyclovir for Viral Uveitis |
|
|
| Recruiting | N/A | 30 | RoW | Acyclovir | Xiaomin Zhang | Uveitis | 12/19 | 12/21 | | |
NCT05592717: A Study of YUTIQ® 0.18 mg Intravitreal Implant for the Management of Chronic Non-infectious Uveitis |
|
|
| Recruiting | N/A | 15 | RoW | Yutiq | Tianjin Medical University | Uveitis, YUTIQ | 11/25 | 11/26 | | |
NCT05627739: A Study of Mycophenolate Mofetil Combined With Glucocorticoid Therapy in Relapse Vogt-Koyanagi-Harada Disease |
|
|
| Recruiting | N/A | 15 | RoW | Mycophenolate Mofetil | Tianjin Medical University | Vogt-Koyanagi-Harada Disease, Mycophenolate Mofetil | 12/24 | 12/25 | | |
NCT05590416: A Study of Adalimumab in Acute Vogt-Koyanagi-Harada Disease |
|
|
| Recruiting | N/A | 15 | RoW | Adalimumab | Tianjin Medical University | Vogt-Koyanagi-Harada Disease, Adalimumab | 12/24 | 12/24 | | |
| He, yanhua |
EROP, NCT06004843: The Effects of Remimazolam on the Incidence of Hypoxia During Sedated Hysteroscopy for Assisted Reproduction in Overweight or Obese Patients |
|
|
| Not yet recruiting | N/A | 600 | RoW | remimazolam, Propofol | RenJi Hospital | Hypoxia, Hysteroscopy, Overweight or Obesity | 02/26 | 04/26 | | |
| Zou, Haidong |
NCT05449015: Study on the Effect of Two Ways of Cycloplegia on Biological Parameters of Ciliary Muscle |
|
|
| Recruiting | 4 | 144 | RoW | 1% atropine | Shanghai Eye Disease Prevention and Treatment Center | Accomodation, Refractive Errors, Myopia, Cycloplegia | 03/23 | 06/23 | | |
NCT05448989: Efficacy and Safety of 1% Atropine "5+3" Regimen in Children and Adolescents Controlling Myopia |
|
|
| Recruiting | 4 | 192 | RoW | 1% atropine 5+3 | Shanghai Eye Disease Prevention and Treatment Center | Myopia | 12/23 | 12/24 | | |
NCT06708156: The Effectiveness and Safety of Two Low-concentration Atropine Sulfate Eye Drops (0.01%/0.02%) for Delaying the Pediatric Myopia Progression |
|
|
| Recruiting | 3 | 606 | RoW | Atropine sulfate eye drops 0.01%, Atropine sulfate eye drops 0.02%, Placebo eye drops | Oupushifang Pharmaceutical Technology Co., Ltd., Seefunge Pharmaceutical Technology Co., Ltd., AUTEK China Inc. | Myopia, Myopia Progression | 12/26 | 12/27 | | |
NCT05184621: The Effectiveness and Safety of Low-intensity Single-wavelength Red Light in Controlling High Myopia in Children and Adolescents：A Randomized, Controlled, Multicenter Clinical Trial |
|
|
| Completed | N/A | 192 | RoW | Eyesing Redlight Instrument | Shanghai Eye Disease Prevention and Treatment Center, Zuoguan Medical Equipment Co., Ltd. at Suzhou Industrial Park, Children's Hospital of Soochow University, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai East Hospital, The Children's Hospital of Zhejiang University School of Medicine, Shanxi Eye Hospital | Age 3 to 16 Years (Inclusive), Male or Female, Clinical Diagnosis Confirming That Myopia Has Occurred in at Least One Eye, The Guardian Voluntarily Signed the Subject's Informed Consent Form | 04/23 | 04/23 | | |
NCT05532774: Efficacy and Safety of Defocusing Frame Glasses With Artificial Intelligence in Controlling Myopia Progression |
|
|
| Recruiting | N/A | 138 | RoW | AI defocusing frame glasses | Shanghai Eye Disease Prevention and Treatment Center, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shandong University of Traditional Chinese Medicine | Myopia | 09/24 | 11/24 | | |
LAMC, NCT05597163: Efficacy and Safety of Low-concentration Atropine for Myopia Control in Chinese Children and Adolescents |
|
|
| Not yet recruiting | N/A | 588 | NA | low concentration atropine (0.01%), low concentration atropine (0.025%), low concentration atropine (0.05%), Placebo | Shanghai Eye Disease Prevention and Treatment Center, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Peking University People's Hospital, Shandong University of Traditional Chinese Medicine | Myopia, Progressive | 11/24 | 11/25 | | |
| Recruiting | N/A | 2500 | RoW | | Shanghai Eye Disease Prevention and Treatment Center | Diabetic Retinopathy, Visual Impairment, Diabetic Maculopathy | 12/24 | 12/24 | | |
| Recruiting | N/A | 600 | RoW | Diabetes mellitus | Shanghai Eye Disease Prevention and Treatment Center, Children's Hospital of Fudan University | Diabetes Mellitus, Eye Diseases | 01/28 | 01/28 | | |
| Huang, Lei |
NCT05606315: RemImazolam Besylate for ICU-sedation in Patients With Mechanical Ventilation After Oral and Maxillofacial Surgery |
|
|
| Recruiting | 4 | 285 | RoW | Remimazolam Besylate, Propofol, Midazolam | Nanfang Hospital, Southern Medical University, Peking University Shenzhen Hospital | Remimazolam Besylate, Sedation, ICU | 03/24 | 12/24 | | |
NCT06708260: A Phase 2 Study to Evaluate the Efficacy and Safety of ENN0403 in Subjects with DME |
|
|
| Recruiting | 2 | 60 | RoW | ENN0403, low dose, ENN0403, high dose | EnnovaBio | Diabetic Macular Edema (DME) | 12/25 | 02/26 | | |
NCT06737146: Study of MT027 in Patients with Recurrent or Progressive High-grade Glioma |
|
|
| Not yet recruiting | 1 | 12 | RoW | MT027 cells suspension | Suzhou Maximum Bio-tech Co., Ltd. | High-grade Glioma | 06/26 | 12/26 | | |
SMEE, NCT05401045: Effect of a Self-designed MET Exercise Intervention on Cancer-related Fatigue in Patients With Gastric Cancer |
|
|
| Completed | N/A | 119 | RoW | Met exercises | Ruijin Hospital | Neoplasm of Stomach | 06/23 | 07/23 | | |
NCT05501990: Study on the Accessibility and Feasibility of Intelligent Applet for Health Intervention of Cancer Patients |
|
|
| Recruiting | N/A | 800 | RoW | Health intervention based on intelligent applet | Ruijin Hospital | Cancer | 12/24 | 12/25 | | |
| Zhu |
NCT06683651: A Study in Chinese Patients With Acquired Blepharoptosis |
|
|
| Recruiting | 3 | 180 | RoW | STN1013800 ophthalmic solution, STN1013800 ophthalmic solution Liquid Base, without STN1013800 | Santen Pharmaceutical Co., Ltd. | Blepharoptosis | 06/26 | 06/26 | | |
| Active, not recruiting | 3 | 9541 | Europe, Canada, Japan, US, RoW | Obicetrapib, Placebo | NewAmsterdam Pharma, Monash University | Atherosclerotic Cardiovascular Disease | 11/26 | 11/26 | | |
JACKPOT8, NCT04105010: Assessing An Oral Janus Kinase Inhibitor, AZD4205 as Monotherapy in Patients Who Have PTCL |
|
|
| Completed | 2 | 171 | US, RoW | AZD4205 | Dizal Pharmaceuticals | Relapsed or Refractory Peripheral T Cell Lymphoma | 10/23 | 02/24 | | |
NCT05092503: JINZHEN for Treatment of Mild to Moderate COVID-19 |
|
|
| Completed | 1/2 | 60 | US | JINZHEN Granules for Oral Solution, Placebo | Lianyungang Kanion Group, Ltd. | COVID-19 | 05/23 | 05/23 | | |
| Recruiting | 1 | 20 | RoW | Ex vivo Expanded Human Autologous Regulatory T Cells, Routine Care | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School, Shanghai Institute of Materia Medica, Chinese Academy of Sciences | Type 1 Diabetes Mellitus | 12/26 | 12/27 | | |
| Zhao, Shaozhen |
NCT05629390: Trial to Evaluate the Efficacy and Safety of TP-03, LIBRA Study |
|
|
| Completed | 3 | 163 | RoW | Lotilaner, TP-03, S-Misoxam, Vehicle Control | LianBio LLC | Blepharitis | 09/23 | 04/24 | | |
NCT06717152: Efficacy and Safety of SJP-0132 Eye Drops in Chinese Patients With Dry Eye Disease |
|
|
| Recruiting | 3 | 400 | RoW | SJP-0132, Placebo | Senju Pharmaceutical Science & Technology (Beijing) Co., Ltd., Senju Pharmaceutical Co., Ltd. | Dry Eye | 07/25 | 08/25 | | |
| Min, Hanyi |
| Not yet recruiting | 1 | 18 | NA | FT-003 | Frontera Therapeutics, The First Affiliated Hospital of Soochow University, Tianjin Medical University Eye Hospital, Peking Union Medical College Hospital, The First Affiliated Hospital of Zhengzhou University | Neovascular Age-related Macular Degeneration | 11/24 | 12/27 | | |
| Recruiting | 1 | 18 | RoW | FT-003 | Frontera Therapeutics, Tianjin Medical University Eye Hospital, Peking Union Medical College Hospital, The First Affiliated Hospital of Zhengzhou University | Diabetic Macular Edema | 05/25 | 05/28 | | |
